Diagnostic accuracy of cystatin C as a marker of kidney disease in patients with multiple myeloma: calculated glomerular filtration rate formulas are equally useful.

Renal impairment is a common complication of multiple myeloma (1)(2)(3). Standard assessment of kidney function in myeloma patients includes serum creatinine and, in those found to have significant renal impairment, creatinine clearance. This probably underestimates the prevalence of kidney disease. The availability of an improved measure of kidney function would aid in the selection of chemotherapy, improve monitoring of kidney function during bisphosphonate treatment, enable detection of kidney disease at an earlier stage, and improve avoidance of potentially nephrotoxic drugs. The limitations of serum creatinine as a marker of the glomerular filtration rate (GFR) are widely appreciated (4)(5). Creatinine clearance may be more sensitive, but it requires a timed urine collection, which is imprecise (6) and inconvenient (7). For clinical purposes, 51Cr-labeled EDTA clearance provides a surrogate gold standard measure of GFR (6)(8), but it is time-consuming, expensive, and not readily available in many hospitals. Attempts to improve clinical measurement of GFR include the use of creatinine-based formulas, including those proposed by Cockcroft and Gault (9) and Levey and coworkers [Modification of Diet in Renal Disease (MDRD) formula (10) and its simplified version (11)]. These improve GFR estimation compared with serum creatinine alone (12), although considerable limitations persist. Cystatin C is a 13-kDa protein whose plasma concentration reflects GFR. Its superiority over serum creatinine in terms of diagnostic sensitivity for reduced GFR is generally accepted (13)(14)(15)(16)(17)(18)(19)(20)(21), but concerns have been expressed that it may be affected by malignant progression (22)(23)(24)(25)(26). To our knowledge, neither cystatin C nor the MDRD formulas have been evaluated against a gold standard measure of GFR in patients with multiple myeloma. For this …

[1]  D. Newman,et al.  Cystatin C improves the detection of mild renal dysfunction in older patients , 2003, Annals of clinical biochemistry.

[2]  E. Lamb,et al.  Estimation of Glomerular Filtration Rate in Older Patients with Chronic Renal Insufficiency: Is the Modification of Diet in Renal Disease Formula an Improvement? , 2003, Journal of the American Geriatrics Society.

[3]  D. Newman.  Rheumatoid factor can interfere with cystatin C measurement , 2003, Annals of clinical biochemistry.

[4]  E. Lamb,et al.  Rheumatoid factor can interfere with cystatin C measurement. , 2003, Annals of clinical biochemistry.

[5]  J. D. Vos,et al.  Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays , 2002, Oncogene.

[6]  V. Dharnidharka,et al.  Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  W. Janssens,et al.  Serum Cystatin C Concentration Compared with Other Markers of Glomerular Filtration Rate in the Old Old , 2002, Journal of the American Geriatrics Society.

[8]  M. Oellerich,et al.  Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood. , 2002, Clinical chemistry.

[9]  C. Price,et al.  Cystatin C: an improved estimator of glomerular filtration rate? , 2002, Clinical chemistry.

[10]  D. Newman,et al.  Analytical performance of a particle-enhanced nephelometric immunoassay for serum cystatin C using rate analysis. , 2001, Clinical chemistry.

[11]  C P Price,et al.  Serum cystatin C in patients with myeloma. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[12]  O. Djurdjev,et al.  Screening for renal disease using serum creatinine: who are we missing? , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  P. Taylor,et al.  Simultaneous Quantification of Tacrolimus and Sirolimus, in Human Blood, by High-Performance Liquid Chromatography–Tandem Mass Spectrometry , 2000, Therapeutic drug monitoring.

[14]  David Roth,et al.  A simplified equation to predict glomerular filtration rate from serum creatinine , 2000 .

[15]  L. Dworkin,et al.  Cystatin C measurement: improved detection of mild decrements in glomerular filtration rate versus creatinine-based estimates? , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  C. Price,et al.  Developments in the assessment of glomerular filtration rate. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[17]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[18]  N. Brünner,et al.  Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression. , 1998, Clinical chemistry.

[19]  M. Mitsuhashi,et al.  Direct reverse transcription-PCR on oligo(dT)-immobilized polypropylene microplates after capturing total mRNA from crude cell lysates. , 1998, Clinical chemistry.

[20]  C. Winearls,et al.  Presentation and survival of patients with severe renal failure and myeloma. , 1997, QJM : monthly journal of the Association of Physicians.

[21]  J. Kos,et al.  Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  V. Turk,et al.  Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines , 1997, Clinical & Experimental Metastasis.

[23]  M D Blaufox,et al.  Report of the Radionuclides in Nephrourology Committee on renal clearance. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  C. Winearls,et al.  Acute myeloma kidney. , 1995, Kidney international.

[25]  P. Nilsson-ehle,et al.  Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. , 1994, Clinical chemistry.

[26]  M. Abrahamson,et al.  Cystatin C and cathepsin B in human colon carcinoma: Expression by cell lines and matrix degradation , 1992, International journal of cancer.

[27]  N. Madias,et al.  Serum creatinine as an index of renal function: new insights into old concepts. , 1992, Clinical chemistry.

[28]  W. J. Johnson,et al.  Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy. , 1990, Archives of internal medicine.

[29]  D. DuBois,et al.  A formula to estimate the approximate surface area if height and weight be known , 1989 .

[30]  R. B. Payne.  Creatinine Clearance: A Redundant Clinical Investigation , 1986, Annals of clinical biochemistry.

[31]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[32]  J. Bröchner-Mortensen,et al.  Renal inulin clearance versus total plasma clearance of 51Cr-EDTA. , 1969, Scandinavian journal of clinical and laboratory investigation.

[33]  K Doqi,et al.  clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification , 2002 .

[34]  D. Fliser,et al.  Serum cystatin C concentration as a marker of renal dysfunction in the elderly. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  Not Available Not Available,et al.  Literature Abstracts , 2001, Pediatric Nephrology.

[36]  C. Price,et al.  Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. , 1995, Kidney international.

[37]  J. Bröchner-Mortensen,et al.  Selection of routine method for determination of glomerular filtration rate in adult patients. , 1976, Scandinavian journal of clinical and laboratory investigation.